Cholinergic stimulation with pyridostigmine improves autonomic function in infarcted rats

Clinical and Experimental Pharmacology and Physiology

Volumn 40, Issue 9, 2013, Pages 610-616

  De La Fuente, Raquel N ^a   Rodrigues, Bruno ^a,b   Moraes Silva, Ivana C ^a   Souza, Leandro E ^a   Sirvente, Raquel ^a   Mostarda, Cristiano ^a   De Angelis, Kátia ^c   Soares, Pedro P ^d   Lacchini, Silvia ^a   Consolim Colombo, Fernanda ^a   Irigoyen, Maria Cláudia ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO JUDAS TADEU UNIVERSITY   (Brazil)

^c Nove de Julho University   (Brazil)

^d FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

Cardiac autonomic function; Cardiovascular function; Myocardial infarction; Pyridostigmine bromide

Indexed keywords

DRINKING WATER; PYRIDOSTIGMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BRADYCARDIA; CHOLINERGIC STIMULATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; HEART CATHETERIZATION; HEART HEMODYNAMICS; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HEART RATE VARIABILITY; HEART VENTRICLE FUNCTION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSORECEPTOR REFLEX; RAT; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; VAGUS TONE;

CARDIAC AUTONOMIC FUNCTION; CARDIOVASCULAR FUNCTION; MYOCARDIAL INFARCTION; PYRIDOSTIGMINE BROMIDE;

ANIMALS; BAROREFLEX; BLOOD PRESSURE; CHOLINERGIC AGENTS; ECHOCARDIOGRAPHY; HEART RATE; HEART VENTRICLES; MALE; MYOCARDIAL INFARCTION; PYRIDOSTIGMINE BROMIDE; RATS; RATS, WISTAR; VENTRICULAR FUNCTION, LEFT;

EID: 84882982214     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12121     Document Type: Article

References (42)

1. Roger VL, Go AS, Lloyd-Jones DM et al. Heart disease and stroke statistics-2012 update: A report from the American Heart Association. Circulation 2012; 125: e2-220.
2. Thygesen K, Alpert JS, Jaffe AS et al. Third universal definition of myocardial infarction. Circulation 2012; 126: 2020-35.
3. La Rovere MT, Pinna GD, Hohnloser SH et al. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: Implications for clinical trials. Circulation 2001; 103: 2072-7.
4. La Rovere MT, Bigger Jr. JT, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 1998; 351: 478-84.
5. Mortara A, La Rovere MT, Pinna GD et al. Arterial baroreflex modulation of heart rate in chronic heart failure: Clinical and hemodynamic correlates and prognostic implications. Circulation 1997; 96: 3450-8.
6. Nolan J, Batin PD, Andrews R et al. Prospective study of heart rate variability and mortality in chronic heart failure: Results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation 1998; 98: 1510-16.
7. Feldman D, Elton TS, Menachemi DM, Wexler RK. Heart rate control with adrenergic blockade: Clinical outcomes in cardiovascular medicine. Vasc. Health Risk Manag. 2010; 6: 387-97.
8. Yusuf S, Anand S, Avezum Jr. A, Flather M, Coutinho M. Treatment for acute myocardial infarction. Overview of randomized clinical trials. Eur. Heart J. 1996; 17 (Suppl. F): 16-29.
9. Vybiral T, Bryg RJ, Maddens ME et al. Effects of transdermal scopolamine on heart rate variability in normal subjects. Am. J. Cardiol. 1990; 65: 604-8.
10. De Ferrari GM, Mantica M, Vanoli E, Hull Jr. SS, Schwartz PJ. Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction. J. Am. Coll. Cardiol. 1993; 22: 1327-34.
11. Kruger C, Landerer V, Zugck C, Ehmke H, Kubler W, Haass M. The bradycardic agent zatebradine enhances baroreflex sensitivity and heart rate variability in rats early after myocardial infarction. Cardiovasc. Res. 2000; 45: 900-12.
12. Pedretti RF, Prete G, Foreman RD, Adamson PB, Vanoli E. Autonomic modulation during acute myocardial ischemia by low-dose pirenzepine in conscious dogs with a healed myocardial infarction: A comparison with beta-adrenergic blockade. J. Cardiovasc. Pharmacol. 2003; 41: 671-7.
13. Toader E, Cividjian A, Rentero N, McAllen RM, Quintin L. Cardioinhibitory actions of clonidine assessed by cardiac vagal motoneuron recordings. J. Hypertens. 2008; 26: 1169-80.
14. Vanoli E, De Ferrari GM, Stramba-Badiale M, Hull Jr. SS, Foreman RD, Schwartz PJ. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ. Res. 1991; 68: 1471-81.
15. Li M, Zheng C, Sato T, Kawada T, Sugimachi M, Sunagawa K. Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation 2004; 109: 120-4.
16. Morita H, Suzuki G, Haddad W et al. Long-term effects of non-excitatory cardiac contractility modulation electric signals on the progression of heart failure in dogs. Eur. J. Heart Fail. 2004; 6: 145-50.
17. Stramba-Badiale M, Vanoli E, De Ferrari GM, Cerati D, Foreman RD, Schwartz PJ. Sympathetic-parasympathetic interaction and accentuated antagonism in conscious dogs. Am. J. Physiol. 1991; 260: H335-40.
18. Waxman MB, Wald RW. Termination of ventricular tachycardia by an increase in cardiac vagal drive. Circulation 1977; 56: 385-91.
19. Soares PP, da Nobrega AC, Ushizima MR, Irigoyen MC. Cholinergic stimulation with pyridostigmine increases heart rate variability and baroreflex sensitivity in rats. Auton. Neurosci. 2004; 113: 24-31.
20. Nobrega AC, dos Reis AF, Moraes RS, Bastos BG, Ferlin EL, Ribeiro JP. Enhancement of heart rate variability by cholinergic stimulation with pyridostigmine in healthy subjects. Clin. Auton. Res. 2001; 11: 11-17.
21. Nobrega AC, Carvalho AC, Santos KB, Soares PP. Cholinergic stimulation with pyridostigmine blunts the cardiac responses to mental stress. Clin. Auton. Res. 1999; 9: 11-16.
22. Sant'anna ID, de Sousa EB, de Moraes AV, Loures DL, Mesquita ET, da Nóbrega AC. Cardiac function during mental stress: Cholinergic modulation with pyridostigmine in healthy subjects. Clin. Sci. 2003; 105: 161-5.
23. Castro RR, Porphirio G, Serra SM, Nóbrega AC. Cholinergic stimulation with pyridostigmine reduces the QTc interval in coronary artery disease. Braz. J. Med. Biol. Res. 2002; 35: 685-9.
24. Castro RR, Porphirio G, Serra SM, Nóbrega AC. Cholinergic stimulation with pyridostigmine protects against exercise induced myocardial ischaemia. Heart 2004; 90: 1119-23.
25. Behling A, Moraes RS, Rohde LE, Ferlin EL, Nobrega AC, Ribeiro JP. Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure. Am. Heart J. 2003; 146: 494-500.
26. Serra SM, Costa RV, Teixeira De Castro RR, Xavier SS, Nóbrega AC. Cholinergic stimulation improves autonomic and hemodynamic profile during dynamic exercise in patients with heart failure. J. Cardiac Fail. 2009; 15: 124-9.
27. Jorge L, Rodrigues B, Rosa KT et al. Cardiac and peripheral adjustments induced by early exercise training intervention were associated with autonomic improvement in infarcted rats: Role in functional capacity and mortality. Eur. Heart J. 2011; 32: 904-12.
28. Rodrigues B, Rosa KT, Medeiros A et al. Hyperglycemia can delay left ventricular dysfunction but not autonomic damage after myocardial infarction in rodents. Cardiovasc. Diabetol. 2011; 10: 26.
29. Braga LM, Rosa K, Rodrigues B et al. Systemic delivery of adult stem cells improves cardiac function in spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 2008; 35: 113-19.
30. Mostarda C, Rodrigues B, Vane M et al. Autonomic impairment after myocardial infarction: Role in cardiac remodelling and mortality. Clin. Exp. Pharmacol. Physiol. 2010; 37: 447-52.
31. Barboza CA, Rocha LY, Mostarda CT et al. Ventricular and autonomic benefits of exercise training persist after detraining in infarcted rats. Eur. J. Appl. Physiol. 2013; 113: 1137-46.
32. Faris IB, Iannos J, Jamieson GG, Ludbrook J. Comparison of methods for eliciting the baroreceptor-heart rate reflex in conscious rabbits. Clin. Exp. Pharmacol. Physiol. 1980; 7: 281-91.
33. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 1991; 84: 482-92.
34. Bataillard A, Sannajust F, Yoccoz D, Blanchet G, Sentenac-Roumanou H, Sassard J. Cardiovascular consequences of organophosphorus poisoning and of antidotes in conscious unrestrained rats. Pharmacol. Toxicol. 1990; 67: 27-35.
35. Taylor P. Anticholinesterase agents. In: Hardman JG, Limbird LE (eds). Goodman and Gilman's Pharmacological Basis of Therapeutics. McGraw-Hill, New York. 1996; 161-76.
36. Keeler JR, Hurst CG, Dunn MA. Pyridostigmine used as a nerve agent pretreatment under wartime conditions. JAMA 1991; 266: 693-5.
37. Nobrega AC, Carvalho AC, Bastos BG. Resting and reflex heart rate responses during cholinergic stimulation with pyridostigmine in humans. Braz. J. Med. Biol. Res. 1996; 29: 1461-5.
38. De Pontes PV, Bastos BG, Romeo Filho LJ, Mesquita ET, Nobrega AC. Cholinergic stimulation with pyridostigmine, hemodynamic and echocardiographic analysis in healthy subjects. Arq. Bras. Cardiol. 1999; 72: 297-306.
39. Grabe-Guimaraes A, Alves LM, Tibirica E, Nobrega AC. Pyridostigmine blunts the increases in myocardial oxygen demand elicited by the stimulation of the central nervous system in anesthetized rats. Clin. Auton. Res. 1999; 9: 83-9.
40. Nakahara T, Kawada T, Sugimachi M et al. Cholinesterase affects dynamic transduction properties from vagal stimulation to heart rate. Am. J. Physiol. 1998; 275: R541-7.
41. Dias da Silva Valdo J, Viana Públio CC, de Melo Alves R et al. Intravenous amiodarone modifies autonomic balance and increases baroreflex sensitivity in conscious rats. Auton. Neurosci. 2002; 95: 88-96.
42. Olshansky B, Sabbah HN, Hauptman PJ, Colucci WS. Parasympathetic nervous system and heart failure. Pathophysiology and potential implications for therapy. Circulation 2008; 118: 863-71.